logo
Plus   Neg
Share
Email

Victrex Q1 Revenue Down 18%, Says Outlook For H2 Unchanged - Quick Facts

Victrex plc (VCT.L) reported that it saw a weaker start to its 2019 financial year, with expected end-market headwinds, tougher comparatives, some de-stocking and adverse currency.

Overall, the company's first-quarter revenue declined 18 percent to 64.1 million pounds from 78.7 million pounds in the prior-year period. Group sales volume fell 22 percent to 822 tonnes from 1,051 tonnes in the year-ago period.

The company noted that the first-quarter headwinds were predominantly in Automotive and Consumer Electronics markets, principally the ongoing slowdown in Automotive and the associated impact on Value Added Resellers, which sees volumes indirectly supplied to Automotive.

As expected, the first-quarter also saw no volumes supplied for the Large Consumer electronics contract, versus a strong comparative last year.

However, the company added that January and February saw an improvement, with a notable pick-up in Automotive sales.

Looking ahead, Jakob Sigurdsson, Chief Executive of Victrex, said, "Our expectations for the second half are unchanged, with new projects and reduced headwinds supporting our assumptions. With strong structural growth opportunities, a healthy new product pipeline and a highly cash generative business model, we continue to be well-placed for the medium and long term."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Boeing Co. (BA) has finally received an order for its controversial 737 MAX from British Airways parent International Airlines Group (IAG). Boeing Tuesday said the two companies signed a letter of intent at the Paris Air Show for up to 200 Boeing 737 Max airliners, a deal that would be valued at more... The U.S. Food and Drug Administration's adoption of a maximum nicotine rule would be a "potential game changer" for the U.S. tobacco industry, but it could also cut profits for major tobacco companies in the U.S. by half, according to Morgan Stanley analysts. In October, the FDA will publish its proposed rule that regulates the amount of nicotine allowed in cigarettes and other tobacco products. French pharma major Sanofi will tie up with Google to utilize its artificial intelligence and develop a state-of-the-art virtual healthcare innovation lab. The partnership is expected to tap the power of latest data technologies. Sanofi said it plans to use cloud computing and artificial intelligence...
Follow RTT